Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate

Yutaka Fujii1, Takemasa Sakaguchi, Katsuhiro Kiyotani

  • 1Department of Virology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan.

Journal of Virology
|August 7, 2002
PubMed

Insights

Sendai virus (SeV) leader mutations reduce mouse virulence by impairing virus replication in lung cells. These findings highlight host-dependent effects of viral genetic changes on pathogenesis.

Area of Science:

  • Virology
  • Molecular Biology
  • Pathogenesis

Background:

  • Sendai virus (SeV) passage in embryonated eggs attenuates virulence.
  • Specific viral clones exhibit distinct virulence levels.
  • Previous work identified four mutations in an attenuated SeV clone (E15cl2).

Purpose of the Study:

  • To investigate the role of leader sequence mutations in SeV pathogenesis.
  • To determine if leader mutations affect virus replication and virulence in mice.

Main Methods:

  • Recovery of live SeV mutants from cDNA.
  • Assessment of viral pathogenicity and replication in mice.
  • In vitro replication assays in mouse pulmonary epithelial cells and chicken embryo fibroblasts.

Main Results:

  • Single leader mutations (U20A or U24A) slightly reduced SeV pathogenicity.
  • A double leader mutant (U20A/U24A) showed 25-fold attenuated virulence and significantly lower replication in mouse lungs.
  • Leader mutant replication was impaired in mouse pulmonary cells but not chicken embryo fibroblasts.

Conclusions:

  • SeV leader mutations contribute to altered virus pathogenesis.
  • Mutations in the leader sequence affect virus replication in a host-dependent manner.
  • These findings provide insights into the molecular mechanisms of SeV attenuation.